Reaction

Urethral Caruncle reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 64 reports · 2 co-occurring drugs

As of the last recalculation, Urethral Caruncle appears in 64 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is TELMISARTAN (PRR 388.4).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Telmisartan16388.4388.7
Linagliptin16380.1380.4

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.